Suppr超能文献

基于人群的结直肠癌患者队列中淋巴结比率的预后价值。

The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients.

机构信息

Chirurgische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

出版信息

Ann Surg. 2010 Jun;251(6):1070-8. doi: 10.1097/SLA.0b013e3181d7789d.

Abstract

OBJECTIVE

We analyzed 3 previously identified cut-off values of lymph node ratios (0.17, 0.41, and 0.69) in a large population-based collective of patients with colorectal cancer for their prognostic value.

SUMMARY BACKGROUND DATA

The lymph node ratio (LNR) (relation of tumor-infiltrated to total examined lymph nodes) has a high prognostic impact, but the relevant cut-off values are not determined.

METHODS

Patients (N = 27,803) with a primary colorectal cancer diagnosed and operated in the Munich region between 1991 and 2006 were registered in the Munich Cancer Registry. Lymph node numbers and survival data were available for 17,309 patients with a mean follow-up of 5.9 years.

RESULTS

The mean number (+/-SD) of resected lymph nodes was 16.8 +/- 8.4. Twelve or more lymph nodes were resected in 76.8%. Estimated 5-year overall survival decreased significantly with increasing LNR: LNR = 0 in 71.4%, LNR 0.01 to 0.17 in 52.4%, LNR 0.18 to 0.41 in 33.3%, LNR 0.42 to 0.69 in 19.8%, and LNR > or = 0.70 in 8.3% (P < 0.001). Multivariable survival analyses identified separately both LNR and pN- category, as well as number of resected lymph nodes, patient's age, tumor location, pT-category, pM-status, R-status, tumor grade, and year of operation as independent prognostic factors.

CONCLUSION

: The 3 cut-off values of LNRs had strong independent prognostic value in a population-based collective of patients with colorectal cancer. The LNR should be routinely reported and included in the American Joint Committee on Cancer staging system. Nevertheless, the benefit of lymphadenectomy on survival is still unclear.

摘要

目的

我们分析了在一个大型的基于人群的结直肠癌患者群体中,先前确定的三个淋巴结比值(LNR)截断值(0.17、0.41 和 0.69)的预后价值。

摘要背景数据

LNR(肿瘤浸润淋巴结与总检查淋巴结的比值)具有很高的预后影响,但相关的截断值尚未确定。

方法

在 1991 年至 2006 年间,慕尼黑地区诊断和手术治疗的原发性结直肠癌患者被登记在慕尼黑癌症登记处。共有 17309 名患者的淋巴结数量和生存数据可用于分析,平均随访时间为 5.9 年。

结果

切除的淋巴结的平均值(+/-SD)为 16.8 +/- 8.4。12 个或更多的淋巴结被切除的比例为 76.8%。随着 LNR 的增加,估计的 5 年总生存率显著下降:LNR=0 的患者占 71.4%,LNR 0.01 至 0.17 的患者占 52.4%,LNR 0.18 至 0.41 的患者占 33.3%,LNR 0.42 至 0.69 的患者占 19.8%,LNR≥0.70 的患者占 8.3%(P<0.001)。多变量生存分析分别确定了 LNR 和 pN 类别、切除的淋巴结数量、患者年龄、肿瘤位置、pT 类别、pM 状态、R 状态、肿瘤分级以及手术年份作为独立的预后因素。

结论

LNR 的这 3 个截断值在基于人群的结直肠癌患者群体中具有很强的独立预后价值。LNR 应该被常规报告并纳入美国癌症联合委员会分期系统。然而,淋巴结切除术对生存的获益仍不清楚。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验